Home › Bipolar Disorder › Washington › Bellevue
Bipolar Disorder clinical trials in Bellevue, WA
4 studies for Bipolar Disorder are looking for participants at sites in and around Bellevue (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
RecruitingPhase 2
- Northwest Clinical Research Center, Bellevue
Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
RecruitingPhase 3
- Northwest Clinical Research Center, Bellevue
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
RecruitingPhase 3
- Northwest Clinical Research Center, Bellevue
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder
RecruitingPhase 2
- Northwest Clinical Research Center /ID# 272847, Bellevue
About Bipolar Disorder
Bipolar disorder is a mood disorder that can cause intense mood swings. It's also called manic depression. Learn about the types, symptoms, treatment, and more.
More about Bipolar Disorder on MedlinePlus
Bipolar Disorder trials in other cities
- Houston, TX9 studies
- New York City, NY7 studies
- Boston, MA7 studies
- Little Rock, AR5 studies
- Hialeah, FL5 studies
- Atlanta, GA5 studies
- Austin, TX5 studies
- Cambridge, MA5 studies
- Cincinnati, OH4 studies
- Anaheim, CA4 studies
- Rochester, MN4 studies
- Orange, CA4 studies
Other studies in Bellevue
- Major Depressive Disorder9 studies
- Ulcerative Colitis6 studies
- Depression5 studies
- Alzheimer's Disease5 studies
- Schizophrenia5 studies
- Crohn's Disease4 studies
- Knee Osteoarthritis4 studies
- Breast Cancer3 studies
- Psychotic Disorders3 studies
- Obesity3 studies
- Generalized Anxiety Disorder3 studies
- Steatotic Liver Disease3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.